Price T Rowe Associates Inc Sarepta Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 504,968 shares of SRPT stock, worth $79.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

504,968

Previous 739,736 31.74%

Holding current value

$79.8 Million

Previous $71.3 Million 8.36%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $22 Million - $33.2 Million	-234,768 Reduced 31.74%	504,968 $65.4 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $3.25 Million - $6.02 Million	-48,220 Reduced 6.12%	739,736 $71.3 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $721,087 - $869,455	7,035 Added 0.9%	787,956 $95.5 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $41.6 Million - $61.4 Million	-390,521 Reduced 33.34%	780,921 $89.4 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $39.3 Million - $52.2 Million	334,749 Added 40.01%	1,171,442 $161 Million

Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $38.5 Million - $50.5 Million	-382,178 Reduced 31.36%	836,693 $108 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $4.17 Million - $6.56 Million	55,024 Added 4.73%	1,218,871 $135 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $1.7 Million - $2.39 Million	27,042 Added 2.38%	1,163,847 $87.2 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $25.3 Million - $36.3 Million	401,247 Added 54.55%	1,136,805 $88.8 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $2.02 Million - $2.6 Million	26,114 Added 3.68%	735,558 $66.2 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $775,015 - $1.09 Million	-11,748 Reduced 1.63%	709,444 $65.6 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $1.18 Million - $1.48 Million	17,039 Added 2.42%	721,192 $56.1 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $43.2 Million - $101 Million	-598,498 Reduced 45.94%	704,153 $52.5 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $164 Million - $233 Million	1,302,651 New	1,302,651 $222 Million

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Sarepta Therapeutics, Inc. Transaction History